CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Goldshleger Ilya Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $23.04 | $115K | 31,475 |
| 2024-02-14 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $52.00 | $260K | 26,475 |
| 2024-02-14 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 20,000 | ||
| 2024-02-14 | Tammenoms Bakker Juliet Director | Purchase | +4,000 | $51.29 | $205K | 29,840 |
| 2024-02-12 | Tammenoms Bakker Juliet Director | Purchase | +4,000 | $50.38 | $202K | 25,840 |
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Option exercise 10b5-1 | +5,365 | $18.90 | $101K | 31,840 |
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $23.04 | $115K | 36,840 |
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,365 | $50.50 | $271K | 31,475 |
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Sale 10b5-1 | −5,000 | $51.00 | $255K | 26,475 |
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,365 | 3,995 | ||
| 2024-02-09 | Goldshleger Ilya Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 25,000 | ||
| 2024-02-06 | Thunen Shelley B Chief Financial Officer | Option exercise | +15,875 | $14.95 | $237K | 29,566 |
| 2024-02-06 | Thunen Shelley B Chief Financial Officer | Sale | −15,875 | $47.47 | $754K | 13,691 |
| 2024-02-06 | Thunen Shelley B Chief Financial Officer | Option exercise · Stock Option (right to buy) | −15,875 | 95,000 | ||
| 2024-02-05 | Corley Jesse Anderson Director | Gift | −46,884 | 30,089 | ||
| 2024-02-05 | Corley Jesse Anderson Director | Gift | +46,884 | 457,460 | ||
| 2024-02-05 | Corley Jesse Anderson Director | Gift | −7,083 | 0 | ||
| 2024-02-05 | Corley Jesse Anderson Director | Gift | +7,083 | 18,708 | ||
| 2024-02-05 | Thunen Shelley B Chief Financial Officer | Option exercise | +6,900 | $4.34 | $30K | 13,691 |
| 2024-02-05 | Thunen Shelley B Chief Financial Officer | Option exercise | +9,125 | $14.95 | $136K | 22,816 |
Page 14 of 15 · 300 trades